Variable loss of antibody potency against SARS-CoV-2 B.1.1.529 (Omicron)
D. J. Sheward, C. Kim, R. A. Ehling…·B. Murrell
This study assesses neutralizing antibody responses against the SARS-CoV-2 Omicron variant, showing reduced potency compared to the pandemic founder but with some cross-neutralizing capacity in vaccinated individuals.